DGHMC
SYNH

Dalton, Greiner, Hartman, Maher & Co’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Dalton, Greiner, Hartman, Maher & Co’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-32,363
Closed -$2.46M – 143
2021
Q1 		$2.46M Sell
32,363
-82,494
-72% -$6.22M 1.94% 2
2020
Q4 		$7.83M Buy
+114,857
New +$7.16M 1.65% 9

Other funds holding SYNH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Dalton, Greiner, Hartman, Maher & Co's SYNH Position: Q2 2021 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2021, closing a stake of 32,363 shares — an estimated $2.46M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in SYNH in Q4 2020 and held it in 2 quarters. The position peaked at $7.83M in Q4 2020. 342 funds tracked by Wall St. Rank hold SYNH as of Q2 2021.

  • Dalton, Greiner, Hartman, Maher & Co reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • Dalton, Greiner, Hartman, Maher & Co sold 32,363 Syneos Health, Inc. Class A Common Stock shares in Q2 2021, an estimated $2.46M.
  • Dalton, Greiner, Hartman, Maher & Co first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 2 quarters.
  • Dalton, Greiner, Hartman, Maher & Co's Syneos Health, Inc. Class A Common Stock position peaked at $7.83M in Q4 2020.
  • 342 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2021.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q2 2021.